| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Marshman Fund Trust II | 11% | $178,084,462 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| BlackRock, Inc. | 10% | -18% | $169,781,023 | -$35,290,072 | 5,768,978 | -17% | BlackRock, Inc. | 31 Mar 2025 |
| VANGUARD GROUP INC | 8.3% | $139,310,113 | 4,733,609 | The Vanguard Group | 31 Dec 2024 | |||
| FMR LLC | 5.4% | -19% | $116,481,431 | -$27,472,267 | 3,112,812 | -19% | FMR LLC | 31 Dec 2025 |
As of 31 Dec 2025, 315 institutional investors reported holding 49,792,301 shares of Harmony Biosciences Holdings, Inc. - COMMON STOCK (HRMY). This represents 86% of the company’s total 57,644,670 outstanding shares.
The largest institutional shareholders of Harmony Biosciences Holdings, Inc. - COMMON STOCK (HRMY) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 7,088,688 | +2.3% | 0% | $265,258,704 |
| VANGUARD GROUP INC | 8.4% | 4,813,357 | -5.6% | 0% | $180,115,819 |
| FMR LLC | 5.4% | 3,112,812 | -19% | 0.01% | $116,481,430 |
| AMERICAN CENTURY COMPANIES INC | 3.2% | 1,841,672 | +10% | 0.03% | $68,915,366 |
| DIMENSIONAL FUND ADVISORS LP | 3.2% | 1,830,726 | +8.2% | 0.01% | $68,506,807 |
| STATE STREET CORP | 2.9% | 1,661,850 | +0.5% | 0% | $62,186,427 |
| LSV ASSET MANAGEMENT | 2.9% | 1,657,093 | +3.9% | 0.14% | $62,008,000 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.6% | 1,491,605 | +15% | 0.03% | $55,815,859 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,270,586 | +0.98% | 0% | $47,551,305 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 1,070,471 | -5.9% | 0.06% | $40,057,025 |
| SG Americas Securities, LLC | 1.7% | 961,667 | +4102% | 0.05% | $35,986,000 |
| MORGAN STANLEY | 1.4% | 817,506 | -3.6% | 0% | $30,591,084 |
| AQR CAPITAL MANAGEMENT LLC | 1.4% | 813,889 | +129% | 0.02% | $30,455,726 |
| Boston Partners | 1.2% | 708,943 | -6% | 0.03% | $26,367,837 |
| GOLDMAN SACHS GROUP INC | 0.99% | 569,362 | -12% | 0% | $21,305,526 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.94% | 541,281 | -5.1% | 0.01% | $20,254,735 |
| BNP PARIBAS FINANCIAL MARKETS | 0.91% | 525,145 | 0% | 0.01% | $19,650,926 |
| NOMURA HOLDINGS INC | 0.88% | 510,024 | +17% | 0.14% | $19,085,098 |
| ARMISTICE CAPITAL, LLC | 0.87% | 500,000 | 0.46% | $18,710,000 | |
| venBio Partners LLC | 0.85% | 489,194 | 0% | 8.5% | $18,305,639 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.8% | 459,134 | +73% | 0.02% | $17,180,794 |
| Invesco Ltd. | 0.78% | 450,805 | +12% | 0% | $16,869,123 |
| CITADEL ADVISORS LLC | 0.73% | 420,410 | +518% | 0.01% | $15,731,743 |
| NORTHERN TRUST CORP | 0.73% | 418,938 | -3.2% | 0% | $15,676,660 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.73% | 417,955 | -8.4% | 0% | $15,639,876 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 49,792,301 | $1,862,570,821 | +$92,861,949 | $37.42 | 315 |
| 2025 Q3 | 47,339,126 | $1,304,886,690 | -$112,498,749 | $27.56 | 292 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,889 | $31.60 | 276 |
| 2025 Q1 | 50,193,424 | $1,664,235,088 | -$100,697,267 | $33.19 | 267 |
| 2024 Q4 | 52,708,406 | $1,813,638,877 | +$62,320,767 | $34.41 | 244 |
| 2024 Q3 | 50,136,635 | $2,005,018,440 | +$11,121,046 | $40.00 | 231 |
| 2024 Q2 | 50,163,988 | $1,513,604,428 | +$34,652,893 | $30.17 | 218 |
| 2024 Q1 | 48,982,561 | $1,644,752,000 | +$41,053,934 | $33.58 | 206 |
| 2023 Q4 | 47,832,583 | $1,544,993,160 | -$51,074,763 | $32.30 | 219 |
| 2023 Q3 | 49,527,453 | $1,623,105,557 | -$85,461,798 | $32.77 | 203 |
| 2023 Q2 | 51,951,129 | $1,828,229,880 | +$28,751,282 | $35.19 | 207 |
| 2023 Q1 | 51,270,566 | $1,674,006,219 | -$29,571,258 | $32.65 | 213 |
| 2022 Q4 | 51,015,535 | $2,810,596,096 | +$34,893,529 | $55.10 | 238 |
| 2022 Q3 | 50,461,165 | $2,237,024,113 | +$91,703,030 | $44.29 | 195 |
| 2022 Q2 | 47,874,920 | $2,335,182,718 | +$99,684,851 | $48.77 | 173 |
| 2022 Q1 | 45,933,803 | $2,235,023,234 | +$79,981,090 | $48.65 | 168 |
| 2021 Q4 | 44,541,354 | $1,899,444,678 | +$107,131,256 | $42.64 | 138 |
| 2021 Q3 | 30,932,269 | $1,185,850,908 | +$116,456,188 | $38.33 | 99 |
| 2021 Q2 | 27,994,218 | $790,282,400 | -$7,611,822 | $28.23 | 79 |
| 2021 Q1 | 27,468,517 | $907,561,000 | -$18,485,709 | $33.04 | 55 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,367 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,000 | $33.90 | 44 |